Non-glycaemic effects mediated via GLP-1 receptor agonists and the potential for exploiting these for therapeutic benefit: focus on liraglutide. [electronic resource]
Producer: 20120509Description: 41-9 p. digitalISSN:- 1463-1326
- Blood Glucose -- drug effects
- Blood Pressure -- drug effects
- Diabetes Mellitus, Type 2 -- drug therapy
- Female
- Glucagon-Like Peptide 1 -- analogs & derivatives
- Glucagon-Like Peptide-1 Receptor
- Humans
- Hypertension -- drug therapy
- Incretins -- metabolism
- Insulin-Secreting Cells -- drug effects
- Liraglutide
- Male
- Neuroprotective Agents -- pharmacology
- Receptors, Glucagon -- agonists
- Weight Loss -- drug effects
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.